
ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings
Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Appointment of Administrators & Nomad Resignation | 2025-03-26 | English | |
| Holding(s) in Company | 2025-03-19 | English | |
| Intention to Appoint Administrators and Suspension | 2025-03-17 | English | |
| Block Listing Return | 2025-03-14 | English | |
| Result of GM | 2025-03-10 | English | |
| Result of AGM | 2025-02-27 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 6770030 | Appointment of Administrators & Nomad Resignation | 2025-03-26 | English | ||
| 5594783 | Holding(s) in Company | 2025-03-19 | English | ||
| 5593384 | Intention to Appoint Administrators and Suspension | 2025-03-17 | English | ||
| 5592659 | Block Listing Return | 2025-03-14 | English | ||
| 5589562 | Result of GM | 2025-03-10 | English | ||
| 5584360 | Result of AGM | 2025-02-27 | English | ||
| 46831556 | Group of companies' accounts made up to 2024-08-31 | 2025-02-25 | English | ||
| 5582904 | Strategic update | 2025-02-24 | English | ||
| 5580577 | Holding(s) in Company | 2025-02-18 | English | ||
| 5578356 | Block Listing Return | 2025-02-12 | English | ||
| 5578364 | Posting of Notice of General Meeting | 2025-02-12 | English | ||
| 5577315 | Final Results | 2025-02-10 | English | ||
| 5574782 | Holding(s) in Company | 2025-02-04 | English | ||
| 5574198 | Notice of Annual General Meeting | 2025-02-03 | English | ||
| 5573375 | Trading Update | 2025-01-31 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ONCIMMUNE HOLDINGS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
D.Western Therapeutics Institute, Inc.
Biotechnology firm developing drugs from a proprietary prot…
|
4576 | JP | Professional, scientific and te… |
|
Ecopia BioSciences Inc.
Developing novel anticancer agents and therapeutic solution…
|
EIA | CA | Professional, scientific and te… |
|
Ectin Research AB
Pharmaceutical company developing novel oncology treatments…
|
ECTIN B | SE | Professional, scientific and te… |
|
EdgeLab S.p.A.
Designs and manufactures marine and underwater solutions, i…
|
ELB | IT | Professional, scientific and te… |
|
Editas Medicine, Inc.
A clinical-stage genome editing company developing CRISPR m…
|
EDIT | US | Professional, scientific and te… |
|
EGF Theramed Health Corp.
Developing psychedelic drugs for mental health, diagnostic …
|
TMED | CA | Professional, scientific and te… |
|
Eikon Therapeutics, Inc.
Integrates live-cell imaging and computing to discover ther…
|
EIKN | US | Professional, scientific and te… |
|
Eledon Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for organ and a…
|
ELDN | US | Professional, scientific and te… |
|
Elicera Therapeutics AB
Clinical-stage immuno-oncology company developing cell and …
|
ELIC | SE | Professional, scientific and te… |
|
Elicio Therapeutics, Inc.
Clinical-stage biotech developing lymph node-targeted immun…
|
ELTX | US | Professional, scientific and te… |
ONCIMMUNE HOLDINGS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7820/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7820 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7820 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7820 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7820}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ONCIMMUNE HOLDINGS PLC (id: 7820)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.